These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18664570)

  • 1. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.
    Vaidya KS; Harihar S; Phadke PA; Stafford LJ; Hurst DR; Hicks DG; Casey G; DeWald DB; Welch DR
    J Biol Chem; 2008 Oct; 283(42):28354-60. PubMed ID: 18664570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.
    DeWald DB; Torabinejad J; Samant RS; Johnston D; Erin N; Shope JC; Xie Y; Welch DR
    Cancer Res; 2005 Feb; 65(3):713-7. PubMed ID: 15705865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation.
    Hedley BD; Vaidya KS; Phadke P; MacKenzie L; Dales DW; Postenka CO; MacDonald IC; Chambers AF
    Clin Exp Metastasis; 2008; 25(7):727-40. PubMed ID: 18543067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.
    Hurst DR; Edmonds MD; Scott GK; Benz CC; Vaidya KS; Welch DR
    Cancer Res; 2009 Feb; 69(4):1279-83. PubMed ID: 19190326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.
    Khotskaya YB; Beck BH; Hurst DR; Han Z; Xia W; Hung MC; Welch DR
    Mol Carcinog; 2014 Dec; 53(12):1011-26. PubMed ID: 24000122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.
    Phadke PA; Vaidya KS; Nash KT; Hurst DR; Welch DR
    Am J Pathol; 2008 Mar; 172(3):809-17. PubMed ID: 18276787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.
    Vaidya KS; Sanchez JJ; Kim EL; Welch DR
    Cancer Lett; 2009 Aug; 281(1):100-7. PubMed ID: 19307053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
    Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
    Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
    Zhang S; Lin QD; DI W
    Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Calpha-mediated breast tumor cell proliferation.
    Sengupta K; Banerjee S; Dhar K; Saxena NK; Mehta S; Campbell DR; Banerjee SK
    Biochemistry; 2006 Sep; 45(35):10698-709. PubMed ID: 16939222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.
    Smith PW; Liu Y; Siefert SA; Moskaluk CA; Petroni GR; Jones DR
    Cancer Lett; 2009 Apr; 276(2):196-203. PubMed ID: 19111386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1.
    Rivera J; Megias D; Bravo J
    J Proteome Res; 2007 Oct; 6(10):4006-18. PubMed ID: 17854218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
    Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
    Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of mechanisms underlying BRMS1 suppression of metastasis.
    Samant RS; Seraj MJ; Saunders MM; Sakamaki TS; Shevde LA; Harms JF; Leonard TO; Goldberg SF; Budgeon L; Meehan WJ; Winter CR; Christensen ND; Verderame MF; Donahue HJ; Welch DR
    Clin Exp Metastasis; 2000; 18(8):683-93. PubMed ID: 11827072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression.
    Champine PJ; Michaelson J; Weimer BC; Welch DR; DeWald DB
    Clin Exp Metastasis; 2007; 24(7):551-65. PubMed ID: 17896182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRMS1: a multifunctional signaling molecule in metastasis.
    Zimmermann RC; Welch DR
    Cancer Metastasis Rev; 2020 Sep; 39(3):755-768. PubMed ID: 32232621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
    Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
    Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
    Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
    Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
    Samant RS; Debies MT; Hurst DR; Moore BP; Shevde LA; Welch DR
    Cancer Lett; 2006 Apr; 235(2):260-5. PubMed ID: 15978719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
    Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
    Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.